Synergistic Antitumor Activity of Alnuctamab (ALNUC; BMS-986349; CC-93269), a BCMA 2+1 T Cell Engager (TCE), and Celmod Agents in Multiple Myeloma (MM) Preclinical Models
| Autor: | Paiva, Bruno *, Gaffney, Bonny *, Burnett, Kelven *, Castiglioni, Paola *, Angelo, Michael *, Pierce, Daniel W. *, Boss, Isaac W. * |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:7054-7055 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|